This website uses cookies to improve your experience. Learn more about cookies and how to manage them.
24 Apr 2020 by Munir Pirmohamed published April 2020
Professor Sir Munir Pirmohamed sets out how the Society is keeping the pharmacology community close during the pandemic.
23 Apr 2020 published April 2020
Dr Anna Zecharia (Director, Policy and Public Affairs) and Kathryn Wilson (Director, Research Dissemination) set out the Society's approach to research dissemination during the COVID-19 pandemic.
06 Apr 2020 published April 2020
We have put a proactive plan in place to protect and reduce risk to our members and staff, while continuing our services during the COVID-19 outbreak.
During the COVID-19 pandemic, our priority is the safety and wellbeing of our community of staff and members, and we will be supporting you in several different ways throughout these uncertain times.
01 Apr 2020 by Rachel Lambert-Forsyth in Your Society published April 2020
Read Rachel's first blog on joining the Society in unprecedented times
25 Feb 2020 by Munir Pirmohamed in President's message published February 2020
Munir shares some of his highlights from this year's calendar including the President's Lecture.
10 Feb 2020 by Gareth Purvis in Prizes, awards and grants published February 2020
The 2019 Outstanding Young Investigator Award winner shares his experiences from this 3 week visit to the Baker Heart and Diabetes Institute in Melbourne, Australia.
23 Jan 2020 by Munir Pirmohamed in President's message published January 2020
Munir delievers his first message as President and looks to the year ahead.
03 Jan 2020 by Natalie Harrison published January 2020
Our Education, Engagement and Policy Officer, Natalie Harrison, reports on the recent inquiry into ageing held by House of Lords Science and Technology Committee
20 Dec 2019 by Steve Hill in President's message published December 2019
For his final blog, Steve looks back on his time as president and wraps up this year's annual meeting.
26 Nov 2019 by Célian Bertin in Young pharmacologists published November 2019
In the context of the global opioid crisis, the use of morphine as a replacement for validated treatments may seem worrying, as the extent of the practice and its potential risks are unknown. However, analysis of French health insurance databases has provided some answers.
Our magazine publishes articles on current issues and perspectives in pharmacology.
Browse the library